Susan Lisa | Vice President, Investor Relations |
Michael Mahoney | Chairman, President & Chief Executive Officer |
Daniel Brennan | Executive Vice President and Chief Financial Officer |
Ian Meredith | Global Chief Medical Officer and Executive Vice President |
Kenneth Stein | SVP and Chief Medical Officer for Rhythm Management and Global Health Policy |
David Lewis | Morgan Stanley |
Bob Hopkins | Bank of America |
Vijay Kumar | Evercore |
Joanne Wuensch | BMO Capital Markets |
Larry Biegelsen | Wells Fargo |
Josh Jennings | Cowen |
Matt Taylor | UBS |
Chris Pasquale | Guggenheim |
Jason Mills | Canaccord Genuity |
Ladies and gentlemen, thank you for standing by. And welcome to the Boston Scientific Q2 2019 Earnings Call.
Now at this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, instructions will be given at that time. [Operator Instructions] As a reminder, today’s call is being recorded.